Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
13F HOLDINGS REPORT

Pivotal bioVenture Partners Investment Advisor LLC

Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0001012975-23-000454

Total Value
$250.7M
Positions
13
Other Managers
1
Confidential Omitted
No
View on SEC.gov

Holdings (13)

#IssuerTicker / CUSIPSharesValue% of Filing
1KARUNA THERAPEUTICS INC48576A100797,008$134.8M53.75%
2VAXCYTE INCPCVX793,036$40.4M16.13%
3OCULIS HOLDING AGOCSAW2,218,754$24.4M9.73%
4INOZYME PHARMA INC45790W1084,494,851$18.9M7.53%
5RALLYBIO CORPRLYB2,404,644$8.1M3.23%
6ARCUTIS BIOTHERAPEUTICS INCARQT1,105,309$5.9M2.34%
7FUSION PHARMACEUTICALS INC36118A1001,560,982$4.1M1.62%
8GRACELL BIOTECHNOLOGIES INC38406L1031,375,000$4.0M1.58%
9EXSCIENTIA PLC30223G102770,500$3.5M1.39%
10VIGIL NEUROSCIENCE INC92673K108560,595$3.0M1.21%
11BOLT BIOTHERAPEUTICS INCBOLT1,891,467$2.0M0.78%
12IO BIOTECH INCIOBT864,197$1.2M0.49%
13ALIGOS THERAPEUTICS INCALGS743,215$555,1820.22%